Evaluation of 30-day hospital readmission after surgery for advanced-stage ovarian cancer in a medicare population.
about
Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236)Prediction model for 30-day morbidity after gynecological malignancy surgeryComparison of Rates and Outcomes of Readmission to Index vs Nonindex Hospitals After Major Cancer Surgery.
P2860
Evaluation of 30-day hospital readmission after surgery for advanced-stage ovarian cancer in a medicare population.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Evaluation of 30-day hospital ...... ncer in a medicare population.
@ast
Evaluation of 30-day hospital ...... ncer in a medicare population.
@en
type
label
Evaluation of 30-day hospital ...... ncer in a medicare population.
@ast
Evaluation of 30-day hospital ...... ncer in a medicare population.
@en
prefLabel
Evaluation of 30-day hospital ...... ncer in a medicare population.
@ast
Evaluation of 30-day hospital ...... ncer in a medicare population.
@en
P2093
P2860
P356
P1476
Evaluation of 30-day hospital ...... ncer in a medicare population.
@en
P2093
Jenny Chang
Ramez N Eskander
Robert E Bristow
P2860
P304
P356
10.1200/JCO.2014.56.7743
P407
P577
2014-11-10T00:00:00Z